vs
H&R BLOCK INC（HRB）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
H&R BLOCK INC的季度营收约是REPLIGEN CORP的1.0倍（$198.9M vs $197.9M），REPLIGEN CORP净利率更高（6.7% vs -121.8%，领先128.5%），REPLIGEN CORP同比增速更快（13.6% vs 11.1%），REPLIGEN CORP自由现金流更多（$17.6M vs $-649.5M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs -69.8%）
H&R Block是美国知名税务服务企业，1955年由亨利·布洛克与理查德·布洛克兄弟在密苏里州堪萨斯城创立，目前业务范围覆盖美国、加拿大、澳大利亚三地，为个人及企业客户提供专业的税务申报、咨询等相关服务，在行业内拥有较高知名度。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
HRB vs RGEN — 直观对比
营收规模更大
HRB
是对方的1.0倍
$197.9M
营收增速更快
RGEN
高出2.6%
11.1%
净利率更高
RGEN
高出128.5%
-121.8%
自由现金流更多
RGEN
多$667.0M
$-649.5M
两年增速更快
RGEN
近两年复合增速
-69.8%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $198.9M | $197.9M |
| 净利润 | $-242.2M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | -160.5% | 9.0% |
| 净利率 | -121.8% | 6.7% |
| 营收同比 | 11.1% | 13.6% |
| 净利润同比 | 0.5% | 143.9% |
| 每股收益（稀释后） | — | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HRBRGEN
| Q4 25 | $198.9M | $197.9M | ||
| Q3 25 | $203.6M | $188.8M | ||
| Q2 25 | $1.1B | $182.4M | ||
| Q1 25 | $2.3B | $169.2M | ||
| Q4 24 | $179.1M | $174.1M | ||
| Q3 24 | $193.8M | $154.9M | ||
| Q2 24 | $1.1B | $154.1M | ||
| Q1 24 | $2.2B | $151.3M |
净利润HRBRGEN
| Q4 25 | $-242.2M | $13.3M | ||
| Q3 25 | $-165.8M | $14.9M | ||
| Q2 25 | $299.4M | $14.9M | ||
| Q1 25 | $722.3M | $5.8M | ||
| Q4 24 | $-243.4M | $-30.3M | ||
| Q3 24 | $-172.6M | $-654.0K | ||
| Q2 24 | $257.8M | $3.3M | ||
| Q1 24 | $690.7M | $2.1M |
毛利率HRBRGEN
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | 57.4% | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% | ||
| Q1 24 | 57.6% | 49.5% |
营业利润率HRBRGEN
| Q4 25 | -160.5% | 9.0% | ||
| Q3 25 | -106.3% | 8.9% | ||
| Q2 25 | 33.1% | 7.6% | ||
| Q1 25 | 42.1% | 3.9% | ||
| Q4 24 | -174.4% | -17.7% | ||
| Q3 24 | -119.8% | -5.1% | ||
| Q2 24 | 33.0% | 1.0% | ||
| Q1 24 | 41.5% | 1.3% |
净利率HRBRGEN
| Q4 25 | -121.8% | 6.7% | ||
| Q3 25 | -81.5% | 7.9% | ||
| Q2 25 | 27.0% | 8.2% | ||
| Q1 25 | 31.7% | 3.4% | ||
| Q4 24 | -135.9% | -17.4% | ||
| Q3 24 | -89.0% | -0.4% | ||
| Q2 24 | 24.3% | 2.2% | ||
| Q1 24 | 31.6% | 1.4% |
每股收益（稀释后）HRBRGEN
| Q4 25 | — | $0.24 | ||
| Q3 25 | — | $0.26 | ||
| Q2 25 | — | $0.26 | ||
| Q1 25 | $5.31 | $0.10 | ||
| Q4 24 | — | $-0.55 | ||
| Q3 24 | — | $-0.01 | ||
| Q2 24 | — | $0.06 | ||
| Q1 24 | $4.86 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $349.2M | $767.6M |
| 总债务越低越好 | $2.4B | $542.2M |
| 股东权益账面价值 | $-823.1M | $2.1B |
| 总资产 | $2.9B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资HRBRGEN
| Q4 25 | $349.2M | $767.6M | ||
| Q3 25 | $376.4M | $748.7M | ||
| Q2 25 | $983.3M | $708.9M | ||
| Q1 25 | $772.9M | $697.2M | ||
| Q4 24 | $320.1M | $757.4M | ||
| Q3 24 | $415.9M | $784.0M | ||
| Q2 24 | $1.1B | $809.1M | ||
| Q1 24 | $794.6M | $780.6M |
总债务HRBRGEN
| Q4 25 | $2.4B | $542.2M | ||
| Q3 25 | $1.7B | $537.9M | ||
| Q2 25 | $1.1B | — | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | $1.9B | $525.6M | ||
| Q3 24 | $1.5B | — | ||
| Q2 24 | $1.5B | — | ||
| Q1 24 | $1.5B | — |
股东权益HRBRGEN
| Q4 25 | $-823.1M | $2.1B | ||
| Q3 25 | $-550.9M | $2.1B | ||
| Q2 25 | $88.9M | $2.1B | ||
| Q1 25 | $-192.8M | $2.0B | ||
| Q4 24 | $-872.5M | $2.0B | ||
| Q3 24 | $-368.1M | $2.0B | ||
| Q2 24 | $90.6M | $2.0B | ||
| Q1 24 | $-129.8M | $2.0B |
总资产HRBRGEN
| Q4 25 | $2.9B | $2.9B | ||
| Q3 25 | $2.6B | $2.9B | ||
| Q2 25 | $3.3B | $2.9B | ||
| Q1 25 | $3.2B | $2.9B | ||
| Q4 24 | $2.7B | $2.8B | ||
| Q3 24 | $2.5B | $2.8B | ||
| Q2 24 | $3.2B | $2.9B | ||
| Q1 24 | $3.2B | $2.8B |
负债/权益比HRBRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | 12.86× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | 16.46× | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-614.0M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $-649.5M | $17.6M |
| 自由现金流率自由现金流/营收 | -326.6% | 8.9% |
| 资本支出强度资本支出/营收 | 17.9% | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | $524.1M | $93.9M |
8季度趋势，按日历期对齐
经营现金流HRBRGEN
| Q4 25 | $-614.0M | $25.7M | ||
| Q3 25 | $-356.8M | $48.1M | ||
| Q2 25 | $251.6M | $28.6M | ||
| Q1 25 | $1.3B | $15.0M | ||
| Q4 24 | $-567.1M | $39.2M | ||
| Q3 24 | $-328.6M | $49.3M | ||
| Q2 24 | $300.6M | $42.2M | ||
| Q1 24 | $1.4B | $44.7M |
自由现金流HRBRGEN
| Q4 25 | $-649.5M | $17.6M | ||
| Q3 25 | $-370.0M | $43.4M | ||
| Q2 25 | $241.3M | $21.5M | ||
| Q1 25 | $1.3B | $11.4M | ||
| Q4 24 | $-597.4M | $33.6M | ||
| Q3 24 | $-347.3M | $42.3M | ||
| Q2 24 | $290.7M | $37.4M | ||
| Q1 24 | $1.3B | $36.4M |
自由现金流率HRBRGEN
| Q4 25 | -326.6% | 8.9% | ||
| Q3 25 | -181.8% | 23.0% | ||
| Q2 25 | 21.7% | 11.8% | ||
| Q1 25 | 57.2% | 6.8% | ||
| Q4 24 | -333.6% | 19.3% | ||
| Q3 24 | -179.2% | 27.3% | ||
| Q2 24 | 27.4% | 24.3% | ||
| Q1 24 | 61.4% | 24.0% |
资本支出强度HRBRGEN
| Q4 25 | 17.9% | 4.1% | ||
| Q3 25 | 6.5% | 2.5% | ||
| Q2 25 | 0.9% | 3.9% | ||
| Q1 25 | 1.0% | 2.1% | ||
| Q4 24 | 17.0% | 3.2% | ||
| Q3 24 | 9.7% | 4.5% | ||
| Q2 24 | 0.9% | 3.1% | ||
| Q1 24 | 1.0% | 5.5% |
现金转化率HRBRGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | — | 3.23× | ||
| Q2 25 | 0.84× | 1.92× | ||
| Q1 25 | 1.83× | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 1.17× | 12.70× | ||
| Q1 24 | 1.97× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
